Malignant Perivascular Epithelioid Cell Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-11-28
Clinical Trial Update: A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) [Phase 1, Phase 2]
Clinical trial update for sirolimus (albumin-bound) in advanced malignant PEComa across Phase 1 and Phase 2.